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Abstract
 Dynamic hyperinﬂ ation (DH) is a pathophysiologic hallmark of Chronic Obstructive 
Pulmonary Disease (COPD). The aim of this study was to investigate the impact 
of emphysema distribution on DH during a maximal cardiopulmonary exercise 
test (CPET) in patients with severe COPD.  This was a retrospective analysis of 
prospectively collected data among severe COPD patients who underwent 
thoracic high-resolution computed tomography, full lung function measurements 
and maximal CPET with inspiratory manouvers as assessment for a lung volume 
reduction procedure. ΔIC was calculated by subtracting the end-exercise 
inspiratory capacity (eIC) from resting IC (rIC) and expressed as a percentage of 
rIC (ΔIC %). Emphysema quantiﬁ cation was conducted at 3 predeﬁ ned levels using 
the syngo PULMO-CT (Siemens AG); a difference >25% between best and worse 
slice was deﬁ ned as heterogeneous emphysema.  Fifty patients with heterogeneous 
(62.7% male; 60.9 ± 7.5 years old; FEV 1 % = 32.4 ± 11.4) and 14 with homogeneous 
emphysema (61.5% male; 62.5 ± 5.9 years old; FEV 1 % = 28.1 ± 10.3) fulﬁ lled the 
enrolment criteria. The groups were matched for all baseline variables. ΔIC% 
was signiﬁ cantly higher in homogeneous emphysema (39.8% ± 9.8% vs.31.2% ± 
13%, p = 0.031), while no other CPET parameter differed between the groups. 
Upper lobe predominance of emphysema correlated positively with peak oxygen 
pulse, peak oxygen uptake and peak respiratory rate, and negatively with ΔIC%. 
Homogeneous emphysema is associated with more DH during maximum exercise 
in COPD patients. 
 Introduction 
 Expiratory ﬂ ow limitation is the pathophysiologic hallmark of Chronic 
Obstructive Pulmonary Disease (COPD). One of the consequences of airﬂ ow 
limitation and permanent parenchymal destruction is lung hyperinﬂ ation 
( 1 , 2 ). Static hyperinﬂ ation is due to the reduced elastic recoil of the lung. 
Dynamic hyperinﬂ ation (DH), which occurs independently or in addition 
to static hyperinﬂ ation, refers to the increase of lung volumes above their 
resting value that occurs with increases in respiratory rate due to expiratory 
ﬂ ow limitation. It is associated both with excessive loading and mechani-
cal disadvantage of inspiratory muscles and with restriction of normal tidal 
volume expansion during exercise ( 2 ). Previous studies have indicated that 
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lung hyperinﬂ ation contributes signiﬁ cantly to exercise 
limitation, exertional dyspnoea and exercise desatura-
tion in COPD patients ( 3 , 4 ). 
 Th oracic computed tomography (CT) allows precise 
assessment of emphysema extent and distribution ( 5 , 6 ) 
and correlation of these parameters with functional and 
pathologic data ( 7 , 8 ). Th e distribution of parenchymal 
damage varies widely between individuals ( 9 ), and its cat-
egorization in homogeneous and heterogeneous emphy-
sema is of clinical signiﬁ cance, since it guides selection 
for surgical and bronchoscopic lung volume reduction 
procedures (LVR) ( 10 – 13 ). Although there are some data 
regarding the association between emphysema distribu-
tion, clinical features and resting lung function values 
in COPD patients of various severities ( 9 , 14 ), no study 
has yet investigated the potential impact of emphysema 
distribution on DH among COPD patients. 
 Th us, we conducted a retrospective study to iden-
tify: (a) diﬀ erences in the degree of DH occurring 
during maximum cardiopulmonary exercise testing 
(CPET) between COPD patients with heterogeneous 
and matched COPD patients with homogeneous 
emphysema and (b) associations between emphysema 
heterogeneity and CPET parameters in the two patient 
groups. Th e primary hypothesis was that patients with 
homogeneous emphysema hyperinﬂ ate more due to the 
diﬀ use distribution of the emphysematous lung tissue 
destruction. 
 Material and Methods 
 Study population 
 Data were collected for COPD outpatients who had 
been assessed at the Respiratory Biomedical Research 
Unit of Royal Brompton Hospital between June 2009, 
and August, 2013 for potential eligibility to undergo 
a bronchoscopic lung volume reduction procedure. 
Th ese included full lung function measurements, tho-
racic high resolution computed tomography (HRCT) 
and breath by breath data from maximal cycling 
CPET with inspiratory capacity manoeuvers every 
minute. Th e COPD patients were in stable clinical 
condition and optimally treated with combinations of 
β2-agonists, anticholinergic drugs and inhaled cortico-
steroids, according to guidelines. All patients had pro-
vided informed consent for their initial participation in 
the studies ( 15 – 18 ). 
 Study Measurements 
 Pulmonary Function Testing 
 Spirometry, gas transfer and lung volumes measure-
ments by body plethysmography were conducted 
using a Compact Lab System (Jaeger, Hoechberg, 
Germany). Arterialized capillary blood samples were 
used to measure arterial blood gases ( 19 ). Th e Euro-
pean Coal and Steel Community predicted values 
were used for lung function measurements ( 20 ) and 
values of carbon monoxide diﬀ usion capacity and 
transfer coeﬃ  cient were adjusted for haemoglobin 
concentration (TLco c and Kco c , respectively) ( 21 ). All 
pulmonary function testing (PFT) values used were 
measured prior to any bronchoscopic intervention 
and within a 6-month interval of both the HRCT and 
the maximal CPET. 
 HRCT acquisition and interpretation 
 Imaging was performed for clinical indications on 4-slice 
multidetector CT (Volume Zoom, Siemens, Erlangen, 
Germany), or 64-slice CT (Somatom Sensation 64, Sie-
mens, Erlangen, Germany). Images were either acquired 
at 10-mm intervals (4-slice CT) or using a volumetric 
acquisition (64-slice CT) in a supine position from the 
lung apices to the bases at full inspiration without the 
use of intravenous contrast. Images were reconstructed 
at thin section width (1.0 mm to 1.5 mm) using a high 
spatial resolution algorithm and reviewed on a work-
station at appropriate window settings for viewing the 
lung parenchyma (window centre = −500HU; window 
width = 1500HU). 
 Images were transferred to a post-processing work-
station (Leonardo, Siemens) and quantitative lung 
density analysis was performed using the Pulmo CT 
program (Siemens AG), which automatically segments 
the lung and calculates pixel attenuation coeﬃ  cients as 
previously described ( 22 ) with a minimum segmenta-
tion threshold of -1024HU (Figure  1 ). Th ree represen-
tative slices of the lungs were analysed: (a) at the level 
where the superior border of the aortic arch appears; (b) 
at the level of the main carina, where clear separation 
of the right and left main bronchi becomes visible; and 
(c) at the lowest level where neither diaphragm nor any 
abdominal viscera are visible. 
 At each level, the program provides a total emphy-
sema index, deﬁ ned as the percentage of whole lung 
with attenuation values below a threshold of -900 HU, as 
well as a severe emphysema index, deﬁ ned as percentage 
of whole lung with attenuation values below a threshold 
of −950 HU.( 23 )(24)(25) An alternative threshold for 
emphysema deﬁ nition of -960 HU has also previously 
been reported and we included this threshold as an 
additional quantitative parameter ( 26 ). 
 To enable us to classify subjects as having either 
homogeneous or heterogeneous emphysema, we 
deﬁ ned heterogeneous emphysema as a diﬀ erence 
of >25% between the highest and lowest quantitative 
emphysema scores obtained, based on previous prec-
edents of visual analysis ( 27 ). 
 In addition, emphysema was treated as a continu-
ous variable and speciﬁ cally as a ratio of average ES of 
the upper and middle slice versus ES of the lower slice 
(UM/L) for both the 950 and 960 emphysema thresh-
olds. A high ratio therefore represented upper lobe pre-
dominance. 
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 Maximal CPET 
 Patients performed incremental symptom-limited 
CPET on a cycle ergometer (Jaeger Ergoline 800), with 
continuous monitoring of pulse oximetry (SaO 2 ), heart 
rate (HR), and a 12-lead electrocardiogram. Th e test 
consisted of three minutes of rest, 1 minute of unloaded 
pedaling at 50–60 rpm, and then a ramp protocol with 
work rate (WR) increasing either 5 or 10 watts/minute, 
followed by 2 minutes of recovery ( 28 ). 
 Gas exchange values and exercise parameters were 
collected breath-by-breath using a Jaeger Oxycon sys-
tem ( 29 , 30 ), allowing measurement of: tidal volume 
(Vt), respiratory rate (RR), oxygen uptake (VO 2 ), carbon 
dioxide production (VCO 2 ), end-tidal oxygen (PETO 2 ) 
and end-tidal carbon dioxide (PETCO 2 ). Th e anaerobic 
threshold (AT), oxygen pulse (VO 2 /HR), respiratory 
exchange ratio (RER), minute ventilation (VE) and the 
ventilatory equivalent for carbon dioxide at peak VO 2
(VE/VCO 2 @VO 2 peak) were also calculated, as previ-
ously described ( 29 ). 
 Each patient performed a total of four inspiratory 
capacity (IC) maneuvers at the beginning and after 
1, 2, and 3 minutes of rest as previously described ( 31 ); 
resting IC (rIC) was calculated by averaging these val-
ues. End-exercise IC (eIC) was calculated by another 
inspiratory maneuver which was conducted during the 
last 30 seconds of peak exercise. ΔIC was utilized as a 
measure of DH and was calculated as rIC-eIC. For every 
patient, ΔIC was expressed as a percentage of rIC, that 
is: ΔIC%  = (ΔIC/rIC) × 100%. All exercise tests were 
performed before any bronchoscopic intervention took 
place and without oxygen supplementation. 
 Statistical analysis 
 Statistical analysis was conducted using the PASW 
(Predictive Analytics Software by SPSS Inc®) version 19 
for Windows 2008. Distribution of values was assessed 
using the Shapiro-Wilk test of normality; continuous 
variables are described as mean±1 standard deviation or 
as median (minimum-maximum), accordingly. Group 
comparisons in PFTs, DH and exercise parameters were 
conducted utilizing either the independent samples 
t -test or the Mann–Whitney test, depending on the nor-
mality of their distribution. Pearson  r or Spearman  rho
were used to describe parametric and non-parametric 
correlations between emphysema distribution indices, 
DH measures, and exercise parameters. Level of  p < 0.05 
was considered signiﬁ cant. 
 Results 
 Baseline characteristics 
 Sixty-four COPD patients (61.3 ± 7.3 years old; 
FEV 1 %predicted = 31.5 ± 11.2%, 61.8 male); fulﬁ lled 
the enrolment criteria and constituted the ﬁ nal study 
population. Fifty patients (78.1%) presented with het-
erogeneous and 14 patients (21.9%) with homogeneous 
emphysema (group Het and group Hom correspond-
ingly). An initial attempt for patients in Hom group to 
match the same number of patients in Het group (1:1 
matching) for age, FEV 1 and TLco c was made. However, 
the two patient groups (N 1 = 14 patients in Hom group 
and N 2 = 50 patients in Het group) were found to be 
already matched not only regarding these three selected 
variables, but also regarding gender, body mass index 
 Figure 1.  (A) Upper slice (at the superior border of the aortic arch) transferred to the post-processing workstation, where quantitative lung density analysis was performed 
using the Pulmo CT program. (B) Histogram of distribution of lung attenuation values, measured in HU in the upper slice (at the superior border of the aortic arch) for several 
potential emphysema thresholds. 
D
ow
nl
oa
de
d 
by
 [I
mp
eri
al 
Co
lle
ge
 L
on
do
n L
ibr
ary
] a
t 0
6:3
3 1
6 N
ov
em
be
r 2
01
5 
Copyright © 2015 Taylor & Francis
4 Boutou et al.
(BMI), rest pulmonary function testing variables (PFTs) 
and gas transfer parameters. Results were identical with 
the use of either emphysema threshold (-950 HU or -960 
HU). Th e baseline demographic characteristics of the 
two groups are presented in  Table 1. 
 Exercise parameters 
 Exercise parameters for both groups are presented in 
Table  2 . Dyspnoea was the reason for CPET termination 
for all patients, and the degree of breathlessness did not 
diﬀ er between groups. Only 15 patients (11 from Het 
group and 4 from Hom group) reached their AT during 
maximal CPET (data not shown); the rest terminated 
the exercise before reaching AT, due to respiratory 
reserve depletion. 
 Patients in the Hom group displayed more DH dur-
ing exercise, as ΔIC% was significantly higher among 
Hom group compared to Het group; 39.8% vs 31.2% 
( p = 0.031). An additional analysis was undertaken, 
utilizing the change from rest to peak exercise values 
of End-Expiratory Lung Volume to Total lung capac-
ity ratio (ΔEELV/TLC); Again, Hom group presented 
with significantly higher ratio, that is greater DH 
during exercise, compared to Het group ( p = 0.035) 
(Table  2 ). No other differences in CPET parameters 
were noted between the two groups (Table  2 and 
Table  3 ). 
 Effect of upper lobe predominance of emphysema 
distribution 
 Th e UM/L ratio of emphysema score for both the 950 
and 960 emphysema thresholds was evaluated; a high 
ratio represents upper lobe predominance. As presented 
in Table  3 , the UM/L ratio established a weak, inverse 
but signiﬁ cant correlation to ΔIC% for both emphysema 
thresholds (Spearman rho = −0.264,  p = 0.049; Spearman 
rho = −0.246,  p = 0.049, correspondingly). Moreover, 
peak VO 2 %predicted, peak VO 2 /HR %predicted and peak 
RR were all positively correlated to UM/L ratio (Table  3 ). 
 Table 1.  Baseline characteristics of the study population 
Heterogeneous 
(n = 50)
Homogenous 
(n = 14)
 P 
Age    60.9 ± 7.5 62.5 ± 5.9 0.471
Gender (%) 0.936
-Male 62.7 61.5
-Female 37.3 38.5
BMI (kg/m 2 )      24 ± 4.5 25.6 ± 3.6 0.243
FEV 1 %predicted    32.4 ± 11.4  28.1 ± 10.3 0.213
FEV 1 /FVC    29.1 ± 7 26.5 ± 6.4 0.216
rIC (lit)     2.2 ± 0.7  2.2 ± 0.5 0.932
rIC /TLC    0.18 ± 0.05  0.17 ± 0.05 0.660
rEELV (lit)     6.1 ± 1.4    6 ± 1.5 0.840
rEELV/TLC    0.73 ± 0.07  0.72 ± 0.06 0.660
TLC %predicted     137 ± 16.4 132.4 ± 9.4 0.198
RV %predicted 232.8 ± 44.6 220.7 ± 32 0.365
RV/TLC (%)    61.6 ± 8.5 60.8 ± 5.2 0.757
FRC %predicted   189.9 ± 31.5 168.8 ± 47.4 0.059
TLCOc %predicted    34.1 ± 10  33.3 ± 11.5 0.867
KCOc %predicted    45.8 ± 12    40 ± 12.1 0.300
PaO 2 (kPa)     9.6 ± 1.3 9.2 ± 1 0.527
PaCO 2 (kPa)     4.8 ± 0.7  5.1 ± 1.5 0.398
 BMI: Body Mass Index; FEV 1 : Forced Expiratory Volume in 1 second; FVC: Forced Vital 
Capacity; TLC: Total Lung Capacity; EELV: End-Expiratory Lung Volume; RV: Residual 
Volume; FRC: Functional Residual Capacity; TLco c : Carbon monoxide transfer factor 
corrected for haemoglobin; Kco c : Carbon monoxide transfer coefﬁ cient corrected for 
haemoglobin; PaO 2 : arterial Oxygen Partial Pressure; PaCO 2 : arterial Carbon Dioxide 
Partial Pressure. 
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 Table 2.  Comparison of exercise parameters between patients with 
heterogeneous and homogeneous emphysema 
Heterogeneous 
(n = 50)
Homogenous 
(n = 14)
 p 
eIC (lit) 1.5 ± 0.5 1.3 ± 0.3 0.240
eIC/TLC 0.18 ± 0.05 0.17 ± 0.05 0.385
ΔIC %     31.2 ± 13      39.8 ± 9.8  0.031 
eEELV (lit) 6.8 ± 1.4 6.9 ± 1.5 0.833
eEELV/TLC 0.82 ± 0.05 0.83 ± 0.05 0.385
ΔEELV/TLC 0.079 (0.01–0.21) 0.119 (0.06–0.15)  0.035 
eIRV (lit) 0.4 ± 0.3 0.3 ± 0.3 0.352
rBorg 1(0–5) 2(0–2) 0.441
pBorg 7(4–10) 7(5–7) 0.807
ΔBorg 5(1–9) 5(3-7) 0.852
Peak VE (lit/min) 34(15–47) 32(18–84) 0.593
Peak Vt (lit/min) 1.1(0.5–2.1) 1(0.7–1.4) 0.739
Peak VO 2 (ml/kg/min) 13.3(7.9–26.2) 12.5(7.8–26) 0.349
Peak VO 2 %predicted 49(13–99) 44(14–67) 0.246
Peak WR %predicted 26(5–73) 34(12–59) 0.361
Peak VCO 2 (ml/min) 780.6(404–2023.4) 934.6(361–1025) 0.944
RER 0.9(0.4–1.3) 0.9(0.4–1.5) 0.662
Peak HR %predicted 75.5(42–106) 75.5(65–86) 0.802
PETO 2 (kPa) 14.9(13–18) 14.9(11.4–16) 0.441
PETCO 2 (kPa) 4.7(2.3–6.7) 4.6(3.6–8.3) 0.687
Peak VE/VCO 2 39.4(26.9–72.2) 41.6(21–48.3) 0.834
Peak VO 2 /HR %predicted 66.6(14.4–112.3) 59(20.4–82) 0.131
RR (breaths/min)     32.9 ± 8.9    31.2 ± 9.4 0.545
rSPO 2 (%) 94.5(88–99) 96(91–98) 0.323
pSPO 2 (%) 89(79–98) 89(80–95) 0.869
ΔSPO 2 (%) 6(0–12) 6.5(3–11) 0.674
 e: end-exercise values; IC: Inspiratory Capacity; EELV: End-Expiratory Lung 
Volume; TLC: Total Lung Capacity; IRV: Inspiratory Residual Volume; rBorg: rest 
Borg scale score; pBorg: peak Borg scale score; VE: Minute ventilation; Vt: Tidal 
Volume; VO 2 : Oxygen Consumption; WR: Work Rate; VCO 2 : Carbon Dioxide Produc-
tion; RER: Respiratory Exchange Ratio; HR: Heart Rate; PETO 2 : End Expiratory 
Oxygen partial pressure; PETCO2: End Expiratory Carbon Dioxide partial pres-
sure; VE/VCO 2 : Ventilatory Equivalent for Carbon Dioxide; VO 2 /HR: Oxygen Pulse; 
rSPO 2 : rest arterial Oxygen Saturation; pSPO 2 : peak arterial Oxygen Saturation. 
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 Discussion 
 We aimed to investigate whether the distribution of 
emphysema has any impact on dynamic lung volumes 
during exercise in patients with COPD. Th e primary 
hypothesis was conﬁ rmed; we found that patients with 
homogenous emphysema hyperinﬂ ated more than those 
with heterogeneous disease, although no diﬀ erences in 
other exercise parameters were noted. Furthermore, 
a measure of upper lobe predominance (UM/L ratio) 
correlated inversely with DH, and positively with peak 
oxygen consumption, peak oxygen pulse and peak RR. 
 Signiﬁ cance of ﬁ ndings 
 Emphysema distribution varies signiﬁ cantly among 
individuals and possibly represents diﬀ erent pathogenic 
patterns of disease development ( 9 ). Th ree diﬀ erent 
subtypes of emphysema have been recognized: (a) cen-
triacinar emphysema, which predominantly involves 
the upper lobes and is associated with long-standing 
cigarette smoking, (b) panacinar emphysema, which 
mainly involves the lower lobes and is frequently found 
in patients with alpha-1 antitrypsin deﬁ ciency and (c) 
distal acinar emphysema, which tends to occur adjacent 
to the pleura or the ﬁ brous septa ( 32 ). 
 Th ese pathologic lesions are found in various combi-
nations in each patient, comprising a heterogeneous or 
homogeneous emphysema pattern, as classiﬁ ed by CT 
imaging ( 32 , 33 ). Mair et al. indicated that emphysema 
distribution is associated with several clinical features, 
such as FEV 1 , BMI, BODE index and health status;(9) 
however, these associations were most evident among 
patients with core versus rind predominant, rather than 
upper versus lower predominant emphysema. Of note, 
the presence of heterogeneity has been repeatedly asso-
ciated with improved outcomes and increased survival 
after a LVR procedure ( 12 , 13 , 34 ). Although the theo-
retical background of these interventions is the restora-
tion of lung elastic recoil and the improvement of lung 
mechanics, the impact of emphysema distribution itself 
on DH has not previously been assessed. 
 Both the pathological hallmarks of COPD, airway 
inﬂ ammation and parenchymal destruction contrib-
ute to the development of DH.( 35 ) During exercise, 
increased airway resistance and decreased elastic recoil 
result in increased time constants for alveolar units, so 
as RR and expiratory ﬂ ow increase, the expiratory time 
available for exhalation becomes insuﬃ  cient ( 36 , 37 ). 
In our study, patients with a heterogeneous pattern of 
emphysema, that is with unequally distributed paren-
chymal damage, experienced signiﬁ cantly less DH dur-
ing maximal exercise. 
 In patients with heterogeneous emphysema, lung areas 
with distinct destruction coexist with areas where lung 
parenchyma is relatively well preserved ( 32 ). We speculate 
that this coexistence poses a mechanical barrier to the 
further increase of end expiratory lung volume in emphy-
sematous lung areas, resulting in less DH during maximal 
exercise. On the contrary, patients with homogeneous 
emphysema have, by deﬁ nition, more widespread disease 
and diﬀ use ﬂ oppy airways, meaning that mechanical 
restriction to whole lung hyperinﬂ ation is less. 
 Interestingly, no CPET parameter diﬀ ered signiﬁ -
cantly between patients in the Het and Hom groups. It 
is well established that medical or other interventions 
targeting lung hyperinﬂ ation improve exercise tolerance 
among COPD patients ( 38 – 40 ). Tzani et al. reported 
that DH was associated with increased exertional 
dyspnea and reduced maximum exercise capacity in a 
cohort of COPD patients ( 3 ); however, a relatively high 
value of end expiratory lung volume (≥75% TLC) was 
used as a threshold for group categorization, while rest-
ing TLC was signiﬁ cantly higher between patients who 
hyperinﬂ ated compared to those who did not. 
 In another study ΔIC was associated with exercise 
desaturation among male COPD patients with severe 
disease; nevertheless, this study utilized six-minute walk-
ing test, that is a submaximal exercise testing and not 
maximal CPET, so results are not easily comparable ( 4 ). 
In our study, the highly selective patient population, the 
 Table 3.  Correlations between emphysema distribution and exercise 
parameters, for both emphysema thresholds 
Exercise parameter 950 UM/L 960 UM/L
ΔIC %
−0.264* −0.246*
rBorg
−0.018 0.016
pBorg 0.096 0.068
ΔBorg 0.078 0.030
Peak VE (lit/min) 0.186 0.040
Peak Vt (lit/min) 0.025 0.053
Peak VO 2 (ml/kg/min) 0.050 0.033
Peak VO 2 %predicted 0.340** 0.341**
Peak WR %predicted 0.087 0.040
Peak VCO 2 (ml/min) 0.130 0.128
RER 0.075 0.110
Peak HR %predicted
−0.074 −0.086
Peak PETO 2 (kPa) 0.193 0.197
Peak PETCO 2 (kPa) −0.097 −0.109
Peak VE/VCO 2 −0.006 0.010
Peak VO 2 /HR %predicted 0.398**  0.390**
Peak RR (breaths/min) 0.300* 0.266*
rSPO 2 (%) 0.046 0.030
pSPO 2 (%) 0.079 0.069
ΔSPO 2 (%) −0.099 −0.091
 Emphysema distribution is expressed as the UM/L ratio of emphysema score for both 
the 950 and 960 emphysema thresholds; a high ratio represents upper lobe predomi-
nance. IC: Inspiratory Capacity; rBorg: rest Borg scale score; pBorg: peak Borg scale 
score; VE: Minute ventilation; Vt: Tidal Volume; VO 2 : Oxygen Consumption; WR: Work 
Rate; VCO 2 : Carbon Dioxide Production; RER: Respiratory Exchange Ratio; HR: Heart 
Rate; PETO2: End Expiratory Oxygen partial pressure; PETCO 2 : End Expiratory Carbon 
Dioxide partial pressure; VE/VCO 2 : Ventilatory Equivalent for Carbon Dioxide; VO 2 /HR: 
Oxygen Pulse; rSPO 2 : rest arterial oxygen saturation; pSPO 2 : arterial oxygen saturation 
at peak exercise. 
 * Signiﬁ cant correlation at 0.05 level. 
 **Signiﬁ cant correlation at 0.01 level. 
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relatively small absolute diﬀ erence of ΔIC (approximately 
8.5%), and the presence of similarly increased resting 
lung volumes between the groups are the most probable 
causes for this lack of diﬀ erence in measures of dyspnea 
and exercise capacity between patients with homoge-
neous and those with heterogeneous emphysema. 
 When emphysema distribution was treated as a 
continuous variable, weak but signiﬁ cant correlations 
were established with several CPET parameters. Th e 
higher the emphysema heterogeneity with upper lobe 
predominance, as manifested by increased UM/L ratio, 
the lower the ΔIC%, and the higher the peak O 2 con-
sumption and the peak oxygen pulse. Lung hyperinﬂ a-
tion is an important cause of circulatory impairment 
during exercise, through several mechanisms ( 3 , 41 , 42 ). 
 Th e development of an intrinsic positive end-expiratory 
pressure (PEEP) during active expiration and the high 
intrathoracic pressure swings that have to be generated 
to overcome the increased high elastic and resistive 
loads result in functional hypovolemia during exercise 
among COPD patients, which may have an impact on 
stroke volume. ( 35 )(41)(36)(43) Whether the unequal 
distribution of parenchymal destruction itself, as seen 
in heterogeneous emphysema, compromises cardiac 
functions less, irrespectively from the degree of DH, due 
to the potential compensatory eﬀ ect of preserved lung 
areas, is a hypothesis that remains to be tested. 
 Methodological issues 
 Although data were analyzed retrospectively, they were 
collected prospectively minimizing recall bias. COPD 
patients who were included in the study were followed-
up in a single tertiary hospital and were pre-screened for 
assessment as potential patients for a LVR procedure. 
Th us, they presented with severe disease and with a 
higher proportion of heterogeneous emphysema than 
expected. Testing was performed by an experienced and 
highly trained team of physiologists and researchers 
with strict quality control measures in place to minimize 
testing variability. 
 Moreover, patients were matched for other param-
eters which could potentially aﬀ ect DH, such as rest-
ing lung function. Although the categorization of 
emphysema distribution was performed using a well-
established technique, the use of UM/L ratio as a con-
tinuous variable to describe upper-lobe predominance 
in sub analysis has not been reported previously and 
needs to be further validated; Nevertheless its correla-
tion with parameters of exercise capacity and DH is in 
accordance with published literature on emphysema 
heteroneneity ( 3 , 41 ), which strengthens the rationale 
of its use. 
 Conclusions 
In conclusion, we found that patients with homogeneous 
emphysema hyperinﬂ ate signiﬁ cantly more during maxi-
mum exercise than to those with heterogeneous emphy-
sema. Upper lobe predominance was also associated 
with less DH and with a higher peak VO 2 , peak VO 2 /HR 
and peak RR. Th erefore, CT assessed emphysema pat-
tern and degree of heterogeneity may have a role to play 
when phenotyping COPD; however, further prospective 
studies are needed to address this. 
 Abbreviations 
 BMI Body Mass Index
COPD Chronic obstructive pulmonary disease
CPET Cardio pulmonary exercise test
DH Dynamic hyperinﬂ ation
ES Emphysema score
EELV End Expiratory Lung Volume
FEV1 Forced Expiratory Volume in 1 second
FRC Functional Residual Capacity
FVC Forced Vital Capacity
HR Heart Rate
HU Hounsﬁ eld unit
HRCT High resolution computed tomography
eIC End-exercise Inspiratory Capacity
Kcoc  Carbon Dioxide transfer coeﬃ  cient corrected 
for haemoglobin
pBorg peak Borg scale score
PaO2 arterial Oxygen Partial Pressure
PaCO2 arterial Carbon Dioxide Partial Pressure
PETCO2  End Expiratory Carbon Dioxide partial pres-
sure
PETO2 End Expiratory Oxygen partial pressurep
pSPO2 peak arterial Oxygen Saturation
rBorg rest Borg scale score
RER Respiratory Exchange Ratio
rIC rest Inspiratory Capacity
rSPO2 rest arterial Oxygen Saturation
RV Residual Volume
TLC Total Lung Capacity
TLcoc  Carbon Dioxide transfer factor corrected for 
haemoglobin
UM/L  Ratio of upper and middle lobe emphysema 
score to lower lobe
VCO2 Carbon Dioxide Production
VE Minute ventilation
VE/VCO2  Ventilatory Equivalent for Carbon Dioxide
VO2 Oxygen Consumption
VO2/HR Oxygen Pulse
Vt Tidal Volume
WR Work Rate
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